J Stroke.  2019 Sep;21(3):242-258. 10.5853/jos.2019.01963.

Digital Therapeutics: Emerging New Therapy for Neurologic Deficits after Stroke

Affiliations
  • 1School of Medical Sciences, University of Manchester, Manchester, UK.
  • 2Department of Neurology, University of Ulsan College of Medicine, Seoul, Korea. dwkang@amc.seoul.kr
  • 3Nunaps Inc., Seoul, Korea.
  • 4Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Abstract

Digital therapeutics is an evidence-based intervention using high-quality software, with the sole purpose of treatment. As many healthcare systems are encountering high demands of quality outcomes, the need for digital therapeutics is gradually increasing in the clinical field. We conducted review of the implications of digital therapeutics in the treatment of neurological deficits for stroke patients. The implications of digital therapeutics have been discussed in four domains: cognition, speech and aphasia, motor, and vision. It was evident that different forms of digital therapeutics such as online platforms, virtual reality trainings, and iPad applications have been investigated in many trials to test its feasibility in clinical use. Although digital therapeutics may deliver high-quality solutions to healthcare services, the medicalization of digital therapeutics is accompanied with many limitations. Clinically validated digital therapeutics should be developed to prove its efficacy in stroke rehabilitation.

Keyword

Digital therapeutics; Stroke; Cognition; Aphasia; Hemianopia; Hemiplegia

MeSH Terms

Aphasia
Aphasia, Broca
Cognition
Delivery of Health Care
Hemianopsia
Hemiplegia
Humans
Medicalization
Neurologic Manifestations*
Rehabilitation
Stroke*
Full Text Links
  • JOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
    DB Error: unknown error